Literature DB >> 7699401

Role of growth factors in degeneration and regeneration in the central nervous system; clinical experiences with NGF in Parkinson's and Alzheimer's diseases.

L Olson1, L Bäckman, T Ebendal, M Eriksdotter-Jönhagen, B Hoffer, C Humpel, R Freedman, M Giacobini, B Meyerson, A Nordberg.   

Abstract

Neurotrophin-mediated mechanisms are integral to development and maintenance of the adult central nervous system. Neurotrophin expression has been shown to change rapidly in response to many different types of neuronal stress such as excitotoxic injury, mechanical lesions, epileptogenesis and ischemia. It therefore appears as if they are not only to be regarded as target-derived trophic factors in the classical sense, but also as providers of local trophic support and neuronal protection. These discoveries suggest that neurotrophins or compounds with neurotrophin-like actions might become useful in developing new treatment strategies, not only for neurodegenerative diseases, but also for other diseases and injuries to the nervous system including stroke.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7699401     DOI: 10.1007/bf00939233

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  17 in total

1.  Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants.

Authors:  O Lindvall; H Widner; S Rehncrona; P Brundin; P Odin; B Gustavii; R Frackowiak; K L Leenders; G Sawle; J C Rothwell
Journal:  Ann Neurol       Date:  1992-02       Impact factor: 10.422

2.  Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials.

Authors:  E O Backlund; P O Granberg; B Hamberger; E Knutsson; A Mårtensson; G Sedvall; A Seiger; L Olson
Journal:  J Neurosurg       Date:  1985-02       Impact factor: 5.115

Review 3.  The nerve growth factor 35 years later.

Authors:  R Levi-Montalcini
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

4.  Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One-year follow-up of first clinical trial.

Authors:  L Olson; E O Backlund; T Ebendal; R Freedman; B Hamberger; P Hansson; B Hoffer; U Lindblom; B Meyerson; I Strömberg
Journal:  Arch Neurol       Date:  1991-04

5.  Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report).

Authors:  L Olson; A Nordberg; H von Holst; L Bäckman; T Ebendal; I Alafuzoff; K Amberla; P Hartvig; A Herlitz; A Lilja
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1992

6.  IGF-1 influences olfactory bulb maturation. Evidence from anti-IGF-1 antibody treatment of developing grafts in oculo.

Authors:  M M Giacobini; R H Zetterström; D Young; B Hoffer; V Sara; L Olson
Journal:  Brain Res Dev Brain Res       Date:  1995-01-14

7.  Eighteen-month course of two patients with grafts of fetal dopamine neurons for severe Parkinson's disease.

Authors:  B J Hoffer; K L Leenders; D Young; G Gerhardt; G O Zerbe; M Bygdeman; A Seiger; L Olson; I Strömberg; R Freedman
Journal:  Exp Neurol       Date:  1992-12       Impact factor: 5.330

Review 8.  NGF and the treatment of Alzheimer's disease.

Authors:  L Olson
Journal:  Exp Neurol       Date:  1993-11       Impact factor: 5.330

9.  Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen.

Authors:  O Lindvall; E O Backlund; L Farde; G Sedvall; R Freedman; B Hoffer; A Nobin; A Seiger; L Olson
Journal:  Ann Neurol       Date:  1987-10       Impact factor: 10.422

10.  Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo.

Authors:  I Strömberg; L Björklund; M Johansson; A Tomac; F Collins; L Olson; B Hoffer; C Humpel
Journal:  Exp Neurol       Date:  1993-12       Impact factor: 5.330

View more
  5 in total

Review 1.  Localized delivery of proteins in the brain: can transport be customized?

Authors:  M F Haller; W M Saltzman
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

2.  Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity.

Authors:  Ming Tong; Matthew Dong; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

3.  Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain.

Authors:  M J Mahoney; W M Saltzman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

Review 4.  Nerve growth factor: from the early discoveries to the potential clinical use.

Authors:  Luigi Aloe; Maria Luisa Rocco; Patrizia Bianchi; Luigi Manni
Journal:  J Transl Med       Date:  2012-11-29       Impact factor: 5.531

5.  Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine.

Authors:  Beatriz Moreno; Iciar Lopez; Begoña Fernández-Díez; Miroslav Gottlieb; Carlos Matute; María Victoria Sánchez-Gómez; María Domercq; Albert Giralt; Jordi Alberch; Kevin W Collon; Helen Zhang; Jack M Parent; Meritxell Teixido; Ernest Giralt; Valentín Ceña; Inmaculada Posadas; Eva Martínez-Pinilla; Pablo Villoslada; Rafael Franco
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.